首页> 外文OA文献 >Assessment of baseline pretreatment factors and on-treatment virological response to predict sustained virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

【2h】

Assessment of baseline pretreatment factors and on-treatment virological response to predict sustained virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

机译：基线预处理因子和治疗病毒学反应的评估，以预测聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎患者持续的病毒学反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Shi-Chi Wen; Lung-Chih Cheng; Jui-Hung Hsu; Hsin-Wen Lai; Pei-Chen Shih; Chi-Chang Tsai; Wu-Hsien Kuo;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Assessment of baseline pre-treatment factors and on-treatment virological response to predict sustained virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin [J] . Shi-Chi Wen, Lung-Chih Cheng, Jui-Hung Hsu, Advances in Digestive Medicine . 2017,第1期

机译：基线预处理因子和治疗病毒学反应的评估，以预测聚乙二醇干扰素和利巴韦林治疗慢性丙型肝炎患者持续的病毒学反应
2. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin [J] . Pei-yuan Su, Hsu-Heng Yen, Yu-Chun Hsu, Kaohsiung Journal of Medical Sciences . 2016,第7期

机译：通过雅培实时丙型肝炎病毒测定进行快速病毒学应答评估，以预测聚乙二醇化干扰素和利巴韦林治疗的基因型1型丙型肝炎患者的持续病毒学应答
3. Is the rapid virologic response a positive predictive factor of sustained virologic response in all pretreatment status genotype 1 hepatitis c patients treated with peginterferon-alpha2b and ribavirin? [J] . de-Segadas-Soares JA, Villela-Nogueira CA, Perez RM, Journal of clinical gastroenterology . 2009,第4期

机译：在接受peginterferon-alpha2b和利巴韦林治疗的所有治疗前状态基因1型丙型肝炎患者中，快速病毒学应答是否是持续病毒学应答的积极预测因素？
4. Patients with HCV/HIV Co-infection Achieving a Sustained Virological Response Following HCV Treatment with Peginterferon alfa-2a (PEGASYS) plus Ribavirin (COPEGUS) have Improved Health Related Quality of Life [C] . D.T. Dieterich, M. Rodriguez Torres, J.K. Rockstroh International AIDS Conference . 2004

机译：HCV / HIV的患者在用Peginterferon Alfa-2a（Pegasys）加上利巴韦林（Copegegs）后HCV治疗后实现持续的病毒学反应，具有改善的健康相关的生活质量
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. Pretreatment serum interleukin-12 levels in predicting sustained virological response among hepatitis C patients following Pegylated Interferon-α2β plus Ribavirin treatment [O] . Antony Perperas, Demetris Karagiannakis, George Anagnostopoulos, 2013

机译：聚乙二醇干扰素-α2β联合利巴韦林治疗丙型肝炎患者前期血清白细胞介素12水平在预测持续病毒应答中的作用
7. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin [O] . Pei-yuan Su, Hsu-Heng Yen, Yu-Chun Hsu, 2016

机译：通过abbott RealTime丙型肝炎病毒检测快速病毒学应答评估预测聚乙二醇化干扰素和利巴韦林治疗丙型肝炎病毒基因1型患者的持续病毒学应答

Assessment of baseline pretreatment factors and on-treatment virological response to predict sustained virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

著录项

引文网络

相似文献

相关主题

期刊订阅